Venous Diseases Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

Venous Diseases Treatment Trends and Forecast

The future of the global venous diseases treatment market looks promising with opportunities in the sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, venoactive medication, and vena cava filter markets. The global venous diseases treatment market is expected to reach an estimated $9.1 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing incidences of venous diseases, growing awareness towards venous disorders, and rising healthcare expenditure.

A more than 150-page report is developed to help in your business decisions.

Venous Diseases Treatment by Segment

The study includes a forecast for the global venous diseases treatment by product type, disease type, treatment type, end use, and region.

Venous Diseases Treatment Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Sclerotherapy Injection
• Ablation Devices
• Venous Closure Products
• Venous Stents
• Medication
• Others

Venous Diseases Treatment Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Deep Vein Thrombosis
• Chronic Venous Insufficiency
• Pulmonary Embolism
• Superficial Thrombophlebitis
• Varicose Veins
• Others

Venous Diseases Treatment Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

• Sclerotherapy
• Radiofrequency Ablation Therapy
• Laser Treatment
• Ambulatory Phlebectomy
• Vein Ligation & Stripping
• Angioplasty Or Stenting
• Surgeries
• Compression Therapy
• Others

Venous Diseases Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Venous Diseases Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Venous Diseases Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies venous diseases treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the venous diseases treatment companies profiled in this report include-

• Abbott
• Imricor
• Medtronic
• Stryker
• Koninklijke Philips
• Baylis Medical
• Theraclion
• Sonablate
• Boston Scientific
• Olympus

Venous Diseases Treatment Market Insights

Lucintel forecasts that varicose veins will remain the largest segment due to the increasing cases of varicose veins and minimally invasive procedures to treat varicose veins.

Within this market, laser treatment is expected to witness highest growth over the forecast period due to rising demand for minimal invasive procedure with less cure time and om-going technological development to treat venous diseases.

North America will remain the largest region due to growing number of varicose veins diseases among the US population, significantly growing aging population, and technological advancement of diagnosis and treatment in the region.

Features of the Global Venous Diseases Treatment Market

Market Size Estimates: Venous diseases treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Venous diseases treatment market size by various segments, such as by product type, disease type, treatment type, end use, and region in terms of ($B).

Regional Analysis: Venous diseases treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, disease types, treatment types, end uses, and regions for the venous diseases treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the venous diseases treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the venous diseases treatment market size?

Answer: The global venous diseases treatment market is expected to reach an estimated $9.1 billion by 2030.

Q.2 What is the growth forecast for venous diseases treatment market?

Answer: The global venous diseases treatment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the venous diseases treatment market?

Answer: The major drivers for this market are increasing incidences of venous diseases, growing awareness towards venous disorders, and rising healthcare expenditure.

Q4. What are the major segments for venous diseases treatment market?

Answer: The future of the venous diseases treatment market looks promising with opportunities in the sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, venoactive medication, and vena cava filter markets.

Q5. Who are the key venous diseases treatment market companies?

Answer: Some of the key venous diseases treatment companies are as follows:

• Abbott
• Imricor
• Medtronic
• Stryker
• Koninklijke Philips
• Baylis Medical
• Theraclion
• Sonablate
• Boston Scientific
• Olympus

Q6. Which venous diseases treatment market segment will be the largest in future?

Answer: Lucintel forecasts that varicose veins will remain the largest segment due to the increasing cases of varicose veins and minimally invasive procedures to treat varicose veins.

Q7. In venous diseases treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing number of varicose veins diseases among the US population, significantly growing aging population, and technological advancement of diagnosis and treatment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the venous diseases treatment market by product type (sclerotherapy injection, ablation devices, venous closure products, venous stents, medication, and others), disease type (deep vein thrombosis, chronic venous insufficiency, pulmonary embolism, superficial thrombophlebitis, varicose veins, and others), treatment type (sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, and others), end use (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?